- Home
- ICU vs CELU Comparison
ICU vs CELU Comparison
Compare ICU & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICU | CELU |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | 17 | 115 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 17.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ICU | CELU |
|---|---|---|
| Price | $3.18 | $0.62 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 78.4K | ★ 86.9K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $53.00 | N/A |
| Revenue Next Year | $50.00 | $76.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.56 |
| 52 Week High | $5.38 | $4.30 |
Technical Indicators
Market Signals| Indicator | ICU | CELU |
|---|---|---|
| Relative Strength Index (RSI) | 32.11 | 34.37 |
| Support Level | $2.26 | $0.56 |
| Resistance Level | $4.96 | $0.85 |
| Average True Range (ATR) | 0.31 | 0.06 |
| MACD | -0.16 | -0.01 |
| Stochastic Oscillator | 0.00 | 7.87 |
Price Performance
Historical ComparisonAbout ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About CELU Celularity Inc.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.